Alok Dalal
Stock Analyst at Jefferies
(2.27)
# 2,933
Out of 4,411 analysts
79
Total ratings
50%
Success rate
1.3%
Average return
Main Sectors:
Stocks Rated by Alok Dalal
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NSE: ALKEM Alkem Laboratories Limited | Maintained: Buy | ₹6,000 → ₹6,500 | $5,347.00 | +21.56% | 5 | May 29, 2026 | |
| NSE: ENTERO Entero Healthcare Solutions Limited | Maintained: Buy | ₹1,350 → ₹1,500 | $1,119.00 | +34.05% | 6 | May 28, 2026 | |
| NSE: APOLLOHOSP Apollo Hospitals Enterprise Limited | Maintained: Buy | ₹9,120 → ₹9,700 | $8,400.00 | +15.48% | 4 | May 25, 2026 | |
| NSE: MANKIND Mankind Pharma Limited | Maintained: Buy | ₹3,100 → ₹3,000 | $2,362.60 | +26.98% | 6 | May 20, 2026 | |
| NSE: GLAND Gland Pharma Limited | Maintained: Hold | ₹1,970 → ₹2,080 | $2,174.00 | -4.32% | 4 | May 18, 2026 | |
| NSE: MEDANTA Global Health Limited | Maintained: Buy | ₹1,440 → ₹1,500 | $1,242.20 | +20.75% | 5 | May 18, 2026 | |
| NSE: SAILIFE Sai Life Sciences Limited | Maintained: Buy | ₹1,300 → ₹1,270 | $1,201.00 | +5.75% | 4 | May 18, 2026 | |
| NSE: COHANCE Cohance Lifesciences Limited | Downgraded: Sell | ₹300.00 | $432.60 | -30.65% | 1 | May 13, 2026 | |
| NSE: CIPLA Cipla Limited | Maintained: Sell | ₹1,120 | $1,375.20 | -18.56% | 6 | May 8, 2026 | |
| NSE: EMCURE Emcure Pharmaceuticals Limited | Maintained: Buy | ₹1,780 → ₹1,970 | $1,733.00 | +13.68% | 7 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹480.00 → ₹1,100 | $1,377.10 | -20.12% | 3 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹1,380 → ₹1,500 | $1,025.40 | +46.28% | 2 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | ₹2,400 → ₹2,250 | $2,272.60 | -0.99% | 2 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | ₹1,210 → ₹1,100 | $1,277.50 | -13.89% | 2 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹1,620 → ₹1,700 | $1,373.00 | n/a | 3 | May 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹1,350 → ₹1,150 | $1,080.80 | n/a | 3 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹6,280 → ₹6,200 | $6,730.00 | n/a | 2 | May 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹260.00 | $163.79 | n/a | 1 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹2,850 → ₹3,140 | $3,089.50 | n/a | 2 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹890.00 → ₹650.00 | $453.30 | n/a | 2 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹860.00 → ₹850.00 | $969.40 | n/a | 2 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹2,260 → ₹2,265 | $1,805.00 | n/a | 2 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | ₹400.00 | $416.50 | n/a | 1 | Jan 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $68 → $12 | $13.30 | n/a | 4 | Jan 30, 2024 |
Alkem Laboratories Limited
May 29, 2026
Maintained: Buy
Price Target: ₹6,000 → ₹6,500
Current: $5,347.00
Upside: +21.56%
Entero Healthcare Solutions Limited
May 28, 2026
Maintained: Buy
Price Target: ₹1,350 → ₹1,500
Current: $1,119.00
Upside: +34.05%
Apollo Hospitals Enterprise Limited
May 25, 2026
Maintained: Buy
Price Target: ₹9,120 → ₹9,700
Current: $8,400.00
Upside: +15.48%
Mankind Pharma Limited
May 20, 2026
Maintained: Buy
Price Target: ₹3,100 → ₹3,000
Current: $2,362.60
Upside: +26.98%
Gland Pharma Limited
May 18, 2026
Maintained: Hold
Price Target: ₹1,970 → ₹2,080
Current: $2,174.00
Upside: -4.32%
Global Health Limited
May 18, 2026
Maintained: Buy
Price Target: ₹1,440 → ₹1,500
Current: $1,242.20
Upside: +20.75%
Sai Life Sciences Limited
May 18, 2026
Maintained: Buy
Price Target: ₹1,300 → ₹1,270
Current: $1,201.00
Upside: +5.75%
Cohance Lifesciences Limited
May 13, 2026
Downgraded: Sell
Price Target: ₹300.00
Current: $432.60
Upside: -30.65%
Cipla Limited
May 8, 2026
Maintained: Sell
Price Target: ₹1,120
Current: $1,375.20
Upside: -18.56%
Emcure Pharmaceuticals Limited
May 8, 2026
Maintained: Buy
Price Target: ₹1,780 → ₹1,970
Current: $1,733.00
Upside: +13.68%
May 4, 2026
Maintained: Hold
Price Target: ₹480.00 → ₹1,100
Current: $1,377.10
Upside: -20.12%
Aug 14, 2025
Maintained: Buy
Price Target: ₹1,380 → ₹1,500
Current: $1,025.40
Upside: +46.28%
Aug 7, 2025
Upgraded: Buy
Price Target: ₹2,400 → ₹2,250
Current: $2,272.60
Upside: -0.99%
Jul 24, 2025
Maintained: Sell
Price Target: ₹1,210 → ₹1,100
Current: $1,277.50
Upside: -13.89%
May 31, 2025
Maintained: Hold
Price Target: ₹1,620 → ₹1,700
Current: $1,373.00
Upside: n/a
May 21, 2025
Maintained: Buy
Price Target: ₹1,350 → ₹1,150
Current: $1,080.80
Upside: n/a
May 18, 2025
Maintained: Hold
Price Target: ₹6,280 → ₹6,200
Current: $6,730.00
Upside: n/a
May 15, 2025
Maintained: Buy
Price Target: ₹260.00
Current: $163.79
Upside: n/a
Apr 30, 2025
Maintained: Buy
Price Target: ₹2,850 → ₹3,140
Current: $3,089.50
Upside: n/a
Apr 25, 2025
Maintained: Hold
Price Target: ₹890.00 → ₹650.00
Current: $453.30
Upside: n/a
Feb 10, 2025
Maintained: Buy
Price Target: ₹860.00 → ₹850.00
Current: $969.40
Upside: n/a
Jan 31, 2025
Maintained: Buy
Price Target: ₹2,260 → ₹2,265
Current: $1,805.00
Upside: n/a
Jan 6, 2025
Upgraded: Hold
Price Target: ₹400.00
Current: $416.50
Upside: n/a
Jan 30, 2024
Downgraded: Sell
Price Target: $68 → $12
Current: $13.30
Upside: n/a